54
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of action

, , &
Pages 131-138 | Published online: 19 Jul 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

George J Wan, John Niewoehner & Kyle Hayes. (2023) Acthar Gel (RCI): A Narrative Literature Review of Clinical and Economic Evidence. ClinicoEconomics and Outcomes Research 15, pages 499-512.
Read now
Kyle Hayes, Mary P Panaccio, Parul Houston, John Niewoehner, Mohammed Fahim, George J Wan & Bhavna Dhillon. (2021) Real-World Treatment Patterns and Outcomes from an Electronic Medical Records Database for Patients with Rheumatoid Arthritis Treated with Repository Corticotropin Injection. Open Access Rheumatology: Research and Reviews 13, pages 315-323.
Read now
Nancy Ho-Mahler, Beni Turner, Michael Eaddy, Mark L Hanke & Winnie W Nelson. (2020) Treatment with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Dermatomyositis/Polymyositis. Open Access Rheumatology: Research and Reviews 12, pages 21-28.
Read now
Roy Fleischmann & Daniel E. Furst. (2020) Safety of repository corticotropin injection as an adjunctive therapy for the treatment of rheumatoid arthritis. Expert Opinion on Drug Safety 19:8, pages 935-944.
Read now
Peter A Fischer & Ronald J Rapoport. (2018) Repository corticotropin injection in patients with rheumatoid arthritis resistant to biologic therapies. Open Access Rheumatology: Research and Reviews 10, pages 13-19.
Read now

Articles from other publishers (8)

George Iliopoulos & Dimitrios Daoussis. (2023) FDA-APPROVED INDICATIONS OF ADRENOCORTICOTROPIC HORMONE (ACTH) AS A DRUG: DOES IT HAVE A PLACE IN DISEASE MANAGEMENT TODAY?. Central Asian Journal of Medical Hypotheses and Ethics 3:4, pages 220-231.
Crossref
Cynthia Girman, Mary P. Panaccio, Kyle Hayes, John Niewoehner & George J. Wan. (2022) Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review. Advances in Therapy 39:7, pages 3072-3087.
Crossref
Rui Xu, Li Zhao, Jiyu Liu, Lin Cao, Tianyi Zhao, Yiyun Yu, Dandan Xuan, Weiguo Wan, Yu Xue & Hejian Zou. (2022) Natural Adrenocorticotropic Hormone (ACTH) Relieves Acute Inflammation in Gout Patients by Changing the Function of Macrophages. Journal of Healthcare Engineering 2022, pages 1-14.
Crossref
Hema Chaplin, Lewis Carpenter, Anni Raz, Elena Nikiphorou, Heidi Lempp & Sam Norton. (2021) Summarizing current refractory disease definitions in rheumatoid arthritis and polyarticular juvenile idiopathic arthritis: systematic review. Rheumatology 60:8, pages 3540-3552.
Crossref
Kyle Hayes, Mary P. Panaccio, Niti Goel & Mohammed Fahim. (2021) Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis. Rheumatology and Therapy 8:1, pages 327-346.
Crossref
Dima A. Decker, Paul Higgins, Kyle Hayes, Chris Bollinger, Patrice Becker & Dale Wright. (2020) Repository corticotropin injection attenuates collagen-induced arthritic joint structural damage and has enhanced effects in combination with etanercept. BMC Musculoskeletal Disorders 21:1.
Crossref
Roy Fleischmann, Daniel E. Furst, Erin Connolly-Strong, Jingyu Liu, Julie Zhu & Richard Brasington. (2020) Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial. Rheumatology and Therapy 7:2, pages 327-344.
Crossref
Wei Wang, Dong-Yu Guo, Yue-Jun Lin & Ya-Xiong Tao. (2019) Melanocortin Regulation of Inflammation. Frontiers in Endocrinology 10.
Crossref